DIAGTOC

edotreotide 45 mcg

Version I (with 1 vial per carton)

Image for illustration purposes only.

Presentation: Kit consisting of 1 cartridge with 1 vial of 12 mL containing lyophilized powder for solution for injection, equivalent to 45 mcg of edotreotide, for radiopharmaceutical preparation. It comes with a second cartridge containing 1 vial of 7.5 mL, containing 3.5 mL of buffer solution.

Indications: Indicated for the localization of somatostatin receptor positive neuroendocrine tumors in adult patients using PET.

Storage Conditions:

  • Pre-labeling: Valid for 12 months from the manufacturing date under the following conditions: P vial (lyophilized powder): store in a freezer between −25°C and −15°C, protected from light. Auxiliary solution vials: store refrigerated (2°C to 8°C), protected from light.
  • Post-labeling: After complexation with gallium-68 (68Ga), keep the product at room temperature (15°C to 30°C), protected from light, for up to 2 hours.

Registration: MS. 1.7359.0008.003-8

AVAILABLE BY PRESCRIPTION ONLY – RESTRICTED USE TO HOSPITALS.

Contraindications, warnings, adverse reactions, drug interactions, precautions and posology: refer to package leaflet.

Read the package leaflet

R2Pharma products are available only by means of medical prescription from a licensed physician.

IF SYMPTOMS PERSIST, A DOCTOR SHOULD BE CONSULTED.

Contraindications, warnings, adverse reactions, drug interactions, precautions and posology: refer to package leaflet.

The content of this page is destined to health professionals.

R2PHARMA